Advanced Breast Cancer Treatment

Breast Cancer: Stage 3 and Stage 4

We often receive patients with advanced breast cancer—stage 3 and stage 4—who come to us after their bodies have not responded to conventional therapies, or who are seeking options that may help them avoid the harsh side effects of those treatments. While we’ve seen many hopeful outcomes, the best results are often seen in individuals who have not undergone toxic therapies. These patients typically have a stronger immune system, which plays a vital role in how well their bodies can respond to the integrative treatments we offer.

Many of the women who come to CMN Hospital have already gone through chemotherapy, radiation, or other conventional treatments—and they’re still searching for something more. Dr. Payán understands this deeply. His protocols are designed not only to support healing but also to gently detox residual toxicity from prior treatments. For patients whose immune systems have been weakened, he focuses on restoring immune function while providing personalized care that helps the body recover and respond more effectively. Once under his care, patients can finally exhale—Dr. Payán takes over, so they don’t have to worry about what to do next. They remain involved in every step, but they no longer carry the weight of figuring it out alone.

What Makes Triple Negative Breast Cancer (TNBC) Unique?

Triple Negative Breast Cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast cancer. It does not have estrogen, progesterone, or HER2 receptors—meaning the most common hormone therapies and targeted treatments are not effective. It tends to grow quickly and has a higher risk of early recurrence.

At CMN Hospital, Dr. Edgar Payán has successfully treated women with TNBC using his integrative protocol that combines advanced immune therapies with blue scorpion venom. These are women who came to us after exhausting chemotherapy and radiation, often feeling discouraged by the lack of options. Under Dr. Payán’s care, they found renewed hope—and in many cases, significant improvement in quality of life, tumor response, and immune strength.

The scientific foundation of this success lies in a compound called chlorotoxin, found in blue scorpion venom. Research shows that chlorotoxin binds to specific proteins and enzymes—such as chloride channels and matrix metalloproteinases (MMP‑2)—which are highly active in TNBC and other fast-growing tumors. These enzymes help cancer cells invade nearby tissues and spread. Chlorotoxin interferes with this process by binding to those targets and blocking their activity (Díaz‑García et al., 2017).

What makes this especially significant is that these cancer-driving pathways are not commonly found in healthy tissue, making chlorotoxin highly selective. This means it can help slow tumor progression without damaging the body’s healthy cells. At CMN Hospital, we don’t rely on chlorotoxin alone. It’s part of a greater, personalized protocol designed to restore and protect the immune system.

For women with TNBC who complete the full 4-week protocol at CMN Hospital, Dr. Payán includes continued access to blue scorpion venom therapy for use at home. This allows each patient to maintain the immune support and targeted action of chlorotoxin beyond their stay—while being monitored and guided by his medical team.

Scientific Research Citations

• Díaz‑García et al., 2017 – Induction of apoptosis in TNBC (MDA-MB-231) using Rhopalurus junceus venom
• Díaz‑García et al., 2013 – Selective cytotoxicity in breast cancer cell lines from blue scorpion venom
• MDPI Review, 2022 – Mechanisms of scorpion venom in TNBC and ER+ breast cancers
• Chlorotoxin-guided nanoparticles reduce tumor spread in metastatic breast cancer (4T1 model)
• Chlorotoxin affects ER+ breast cancer via ERα/VASP signaling disruption

Hormone-Positive Breast Cancer

Hormone-positive breast cancers—estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), or both—are often treated with hormone-blocking medications. However, many women struggle with the side effects or find their cancer returns after standard therapy. At CMN Hospital, Dr. Payán takes a different approach. He uses blue scorpion venom as part of a comprehensive, immune-restorative protocol that supports the body without introducing new toxicity.

Blue scorpion venom contains chlorotoxin, a compound that helps target abnormal cell behavior while reducing inflammation. When combined with other treatments like dendritic cell therapy, stem cell infusions, and detoxification support, this therapy helps patients regain strength and stabilize their health. For women who complete the 4-week program, Dr. Payán may also recommend continuing blue scorpion venom therapy at home.

Scientific References:

• MDPI Review, 2022 – Scorpion venom pathways in ER+ breast cancers
• Chlorotoxin impacts ER+ cancer via ERα/VASP signaling disruption

Triple-Positive Breast Cancer

Triple-positive breast cancer (ER+, PR+, HER2+) responds to a wider range of conventional treatments—but many women still face recurrence, residual inflammation, or side effects that compromise their quality of life. At CMN Hospital, Dr. Payán uses an integrative, non-toxic protocol that includes blue scorpion venom to help the body stabilize and strengthen beyond conventional care.

Chlorotoxin, a natural compound in blue scorpion venom, binds to receptors overexpressed in HER2-positive cancers and supports immune balance. For women who want to stay proactive in their healing and minimize future risk, this therapy has become a vital part of their recovery plan. Patients who complete the 4-week protocol often continue blue scorpion venom therapy at home, guided by Dr. Payán’s medical team.

Scientific References:

• Targeted nanoparticles with chlorotoxin for HER2-expressing breast cancer
• MDPI Review, 2022 – Scorpion venom applications in HER2+ models

ADVANCED BREAST CANCER TREATMENT